Position in NKTR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$15,950,886
+$6,817,410 QoQ
Shares Held
228,490
+80.0% QoQ
Ownership
0.669%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#38
of 239 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NKTR Over Time
Shares Held
Position Value (USD)
Derivatives in NKTR
reported options exposure · as of Dec 31, 2021CallValue
$371,525
CallShares
1,833
PutValue
$371,525
PutShares
1,833
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026GOLDMAN SACHS GROUP INC holds $13,040,380,016 across 360 Biotechnology names. NKTR ranks #132 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,481,761 | $1,232,765,138 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,163,191 | $725,296,113 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
18,556,458 | $656,713,046 | |
| 4 | TECH |
BIO-TECHNE Corp
|
7,343,324 | $518,805,838 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
2,133,101 | $399,487,154 | |
| 6 | MRNA |
Moderna, Inc.
|
4,671,950 | $327,176,656 | |
| 7 | TNGX |
Tango Therapeutics, Inc.
|
9,980,620 | $311,994,180 | |
| 8 | INCY |
Incyte Corp
|
2,305,782 | $261,383,446 |
All Filings in NKTR
Export CSV
32 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,950,886 | 228,490 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $9,133,476 | 126,942 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $6,248,687 | 147,793 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $4,384,428 | 77,055 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,613,707 | 62,450 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $361,325 | 531,362 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $676,468 | 727,386 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $2,318,477 | 1,783,444 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $2,191,693 | 1,767,495 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $660,584 | 710,306 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $483,766 | 863,869 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $615,878 | 1,026,464 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $755,373 | 1,302,369 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $736,412 | 1,052,019 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $2,449,821 | 1,083,992 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $3,528,373 | 1,102,617 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $2,667,153 | 701,883 | Shares | Defined | 2024-05-14 | |
| 2022-03-31 | $2,648,899 | 491,447 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $371,525 | 27,500 | Call | Defined | 2022-02-17 | |
| 2021-12-31 | $371,525 | 27,500 | Put | Defined | 2022-02-17 | |
| 2021-12-31 | $5,482,317 | 405,797 | Shares | Defined | 2022-02-17 | |
| 2021-09-30 | $404,100 | 22,500 | Put | Defined | 2022-01-20 | |
| 2021-09-30 | $8,249,566 | 459,330 | Shares | Defined | 2022-01-20 | |
| 2021-09-30 | $404,100 | 22,500 | Call | Defined | 2022-01-20 | |
| 2021-06-30 | $514,800 | 30,000 | Call | Defined | 2021-08-13 | |
| 2021-06-30 | $10,577,028 | 616,377 | Shares | Defined | 2021-08-13 | |
| 2021-06-30 | $514,800 | 30,000 | Put | Defined | 2021-08-13 | |
| 2021-03-31 | $9,199,480 | 459,974 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $17,496,978 | 1,029,234 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $15,525,717 | 935,848 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $38,591,275 | 1,666,290 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $32,379,006 | 1,813,950 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||